Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise +500,000 $1.06 $530K 531,000
2026-11-16 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise · Stock Option (right to buy) −500,000 800,000
2026-06-12 DUGGAN ROBERT W Co-Chief Executive Officer Purchase +3,810,000 $13.12 $50.0M 573,883,879
2026-06-04 DUGGAN ROBERT W Co-Chief Executive Officer Purchase +100,000 $14.60 $1.5M 25,824,474
2026-01-02 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +11,232 $8.76 $98K 11,232
2025-10-21 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award +13,980,789 $18.74 $262.0M 570,073,879
2025-10-21 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award +266,808 $18.74 $5.0M 25,724,474
2025-10-21 DUGGAN ROBERT W Co-Chief Executive Officer Purchase +26,680 $18.74 $500K 76,680
2025-09-11 DUGGAN ROBERT W Co-Chief Executive Officer Purchase +5,000 $18.07 $90K 556,093,090
2025-09-10 DUGGAN ROBERT W Co-Chief Executive Officer Purchase +333,394 $17.68 $5.9M 556,088,090
2025-05-30 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise +74,545 $2.64 $197K 555,754,696
2025-05-30 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise · Stock Option (right to buy) −74,545 0
2025-04-29 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +1,040,000 1,040,000
2025-04-29 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +400,000 400,000
2025-04-29 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +9,590,558 9,590,558
2025-04-08 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise +3,985,055 $1.58 $6.3M 555,680,151
2025-04-08 DUGGAN ROBERT W Co-Chief Executive Officer Option exercise · Warrant (right to buy) +3,985,055 0
2025-01-02 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +10,724 $9.18 $98K 10,724
2024-09-11 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award +3,325,991 $22.70 $75.5M 551,695,096
2024-01-02 DUGGAN ROBERT W Co-Chief Executive Officer Grant or award · Stock Option (right to buy) +74,545 $1.32 $98K 74,545

Page 1 of 2 · 27 trades